Literature DB >> 21865482

Serum concentrations of insulin-like growth factor (IGF)-1 and IGF binding protein-3 (IGFBP-3), IGF-1/IGFBP-3 ratio, and markers of bone turnover: reference values for French children and adolescents and z-score comparability with other references.

Corinne Alberti1, Didier Chevenne, Isabelle Mercat, Emilie Josserand, Priscilla Armoogum-Boizeau, Jean Tichet, Juliane Léger.   

Abstract

BACKGROUND: A reference model for converting serum growth factor and bone metabolism markers into an SD score (SDS) is required for clinical practice. We aimed to establish reference values of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein 3 (IGFBP-3) concentrations and bone metabolism markers in French children, to generate a model for converting values into SDS for age, sex, and pubertal stage.
METHODS: We carried out a cross-sectional study of 1119 healthy white children ages 6-20 years. We assessed concentrations of serum IGF-1, IGFBP-3, carboxyterminal telopeptide α1 chain of type I collagen (CrossLaps), and bone alkaline phosphatase concentrations and height, weight, and pubertal stage, and used semiparametric regression to develop a model.
RESULTS: A single regression model to calculate the SDSs with an online calculator was provided. A positive relationship was found between SDS for serum IGF-1 and IGFBP-3, IGF/IGFBP-3 mol/L ratio, and anthropometric parameters (P < 0.0001), with slightly greater effects observed for height than for body mass index (BMI). There was a negative relationship between serum CrossLaps concentration and BMI, and a positive relationship between serum CrossLaps concentration and height. A comparison of serum IGF-1 reference databases for children showed marked variation as a function of age and pubertal group; smooth changes with age and puberty were observed only in our model.
CONCLUSIONS: This new model for the assessment of SDS reference values specific for age, sex, and pubertal stage may help to increase the diagnostic power of these parameters for the assessment of growth and bone metabolism disorders. This study also provides information about the physiological role of height and BMI for the interpretation of these parameters.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865482     DOI: 10.1373/clinchem.2011.169466

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  The Protective Effects of Exclusive Enteral Nutrition Formulas on Growth Factor Expression and the Proximal Tibial Epiphyseal Growth Plate in a TNBS-Induced IBD Rat Model.

Authors:  Jieru Shi; Zhiheng Huang; Yuhuan Wang; Ying Huang
Journal:  Dig Dis Sci       Date:  2015-02-24       Impact factor: 3.199

Review 2.  Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.

Authors:  Aurélie Ladang; Frank Rauch; Edgard Delvin; Etienne Cavalier
Journal:  Calcif Tissue Int       Date:  2022-03-04       Impact factor: 4.333

3.  Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease.

Authors:  Alice Monzani; Michela Perrone; Flavia Prodam; Stefania Moia; Giulia Genoni; Sara Testa; Fabio Paglialonga; Anna Rapa; Gianni Bona; Giovanni Montini; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2017-11-18       Impact factor: 3.714

4.  Sex, Sport, IGF-1 and the Community Effect in Height Hypothesis.

Authors:  Barry Bogin; Michael Hermanussen; Werner F Blum; Christian Aßmann
Journal:  Int J Environ Res Public Health       Date:  2015-05-04       Impact factor: 3.390

5.  Genetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test.

Authors:  Meriem Ouni; Anne-Laure Castell; Agnès Linglart; Pierre Bougnères
Journal:  J Clin Endocrinol Metab       Date:  2015-04-02       Impact factor: 5.958

6.  The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.

Authors:  Meriem Ouni; Yasemin Gunes; Marie-Pierre Belot; Anne-Laure Castell; Delphine Fradin; Pierre Bougnères
Journal:  Clin Epigenetics       Date:  2015-03-13       Impact factor: 6.551

7.  The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness.

Authors:  M Ouni; M P Belot; A L Castell; D Fradin; P Bougnères
Journal:  Pharmacogenomics J       Date:  2015-04-14       Impact factor: 3.550

8.  Comparison of two bone markers with growth evolution in 74 girls with central precocious puberty.

Authors:  Audrey Vincent; Jean-Claude Souberbielle; Raja Brauner
Journal:  BMC Pediatr       Date:  2018-07-09       Impact factor: 2.125

9.  Can growth hormone treatment improve growth in children with severe growth failure due to anorexia nervosa? A preliminary pilot study.

Authors:  Juliane Léger; Anne Fjellestad-Paulsen; Anne Bargiacchi; Catherine Doyen; Emmanuel Ecosse; Jean-Claude Carel; Marie-France Le Heuzey
Journal:  Endocr Connect       Date:  2017-10-16       Impact factor: 3.335

10.  Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.

Authors:  Mohamed A Yassin; Ashraf T Soliman; Vincenzo De Sanctis; Khadra S Yassin; Mohammad Aj Abdulla
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-05-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.